UGA Biopharma*)

Elevate biopharmaceutical production with UGA Biopharma's cutting-edge CHO (Chinese hamster ovary) cell line development expertise (fig. 1). Our comprehensive services cover Cell Line Development (CLD), Upstream Processing (USP), Downstream Processing (DSP), and robust Analytics. We are your partner in delivering top-tier biologics, including biosimilars, which play a pivotal role in expanding access to affordable and high-quality treatments. At UGA Biopharma, we understand that one size does not fit all. That's why we offer tailor-made biopharmaceutical solutions that align with your unique needs and goals. Our CHO cell line development accelerates your journey to market, reducing timelines and costs without sacrificing quality. Your vision is our mission!

Verweise

*)UGA Biopharma GmbH
Neuendorfstr. 20a
16761 Hennigsdorf
E-Mail: info@ugabiopharma.com
www.ugabiopharma.com
pharmind 2023, Nr. 12, Seite 1153